Community/Retail

Today, the Generic Pharmaceutical Association wrote a letter to Rep. Louise Slaughter (D-NY) expressing strong opposition to the Pharmaceutical Stewardship Act, a bill that would increase the cost of prescription medicines without addressing the root causes of drug abuse.

National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to enactment of Oklahoma's S.B. 1150, legislation to boost transparency in generic prescription drug pricing and reimbursement.

Health care stakeholders across the nation are working to address public health needs in creative ways, and many of their solutions involve eliminating the prescription as a barrier to accessing health care.

The FDA has approved the first drug to treat delusions and hallucinations seen in some patients with Parkinson's disease.